CBO: Generics saved $33 billion for Medicare Part D in 2007
WASHINGTON Generic drugs saved Medicare Part D beneficiaries and the program as a whole $33 billion in 2007, according to a new report by the nonpartisan Congressional Budget Office. The CBO expected another $14 billion in annual savings to accrue as many new generics enter the market through 2012.
The main lobby for pharmacy benefit managers said the report also showed the advantages of pharmacy benefit managers.
“Tools pioneered by pharmacy benefit managers — including encouraging the use of generic medications — have lowered costs and expanded access to prescription drugs for seniors in Medicare Part D,” Pharmaceutical Care Management Association president and CEO Mark Merritt said.
The generic drug industry lobby hailed the report as well. “This new CBO study is just one of a continued body of evidence proving that generics are a key cost-saving component of our healthcare system,” a statement by the Generic Pharmaceutical Association read.
According to the market research firm IMS Health, generic drugs accounted for nearly 75% of prescriptions dispensed in the United States, but for just more than 19% of dollars spent.
Study: Smoking cessation can provide health, economic benefits to Calif., nation
SACRAMENTO, Calif. A new study released Wednesday by the American Lung Association, and conducted by researchers at Penn State University, found that helping smokers quit not only saves lives but also offers favorable economic benefits to California and the nation.
“Smoking Cessation: The Economic Benefits” provides a nationwide cost-benefit analysis that compares the societal costs of smoking with the economic benefits of states providing cessation coverage.
There are an estimated 3.8 million people who smoke in California, and the study found that smoking results in costs to the California economy of more than $26 billion. This includes workplace productivity losses of nearly $6 billion, costs of premature death at more than $9 billion and direct medical expenditures of $11 billion.
The Penn State study also calculated the combined medical and premature death costs and workplace productivity losses per pack of cigarettes. The study showed that while the statewide average retail pack of cigarettes in California is $5.17, the true cost of a pack of cigarettes when considering healthcare impacts and workplace productivity losses is $27.07 per pack, a third higher than the $18.05 national average.
The American Lung Association study found that smoking cessation provided a tremendous return on investment for states. For every dollar spent on helping smokers quit, states will see, on average, a return of $1.26. However, the return on investment for California is among the highest in the country at $1.40. Comparative data for all states can be found at LungUSA.org/stop-smoking/tobacco-control-advocacy/reports-resources/cessation-economic-benefits/ .
The study came at an important time, as smoking-cessation provisions are being implemented at the federal level and in California as Senate Bill 220 is awaiting action by Gov. Arnold Schwarzenegger. Sponsored by the American Lung Association in California, the Cancer Society and the Heart Association, SB 220 would require all health plans and insurers to provide coverage of treatments to help people who smoke to quit smoking. If signed into law, SB 220 would represent the most comprehensive smoking-cessation benefits policy in the nation.
“Gov. Schwarzenegger has the opportunity to make a long-lasting difference in the health and lives of future generations of Californians, and we urge him to do so by signing SB 220 into law,” stated Jane Warner, president and CEO of the American Lung Association in California.
Some of the highest rates of smoking are found among people enrolled in Medicaid, the American Lung Association added. The American Lung Association urged California and every state in the nation to provide all Medicaid recipients and state employees with comprehensive, easily accessible tobacco-cessation benefits. A comprehensive cessation benefit includes all seven medications and three types of counseling recommended by the U.S. Public Health Service for tobacco cessation. Only six states now provide comprehensive coverage for Medicaid recipients: Indiana, Massachusetts, Minnesota, Nevada, Oregon and Pennsylvania.
The American Lung Association also recommends that private insurance plans and employers offer comprehensive cessation coverage, and encourages states to require them to cover these treatments. Only seven states have such requirements now: Colorado, Maryland, New Jersey, New Mexico, North Dakota, Oregon and Rhode Island.
Thompson Brands’ Adora supplement arrives at retail
MERIDEN, Conn. Thompson Brands on Wednesday launched its Adora calcium and vitamin D supplement, an all-natural chocolate that is 30 calories per serving.
"After a great deal of research, we have perfected the formula for a delicious-tasting calcium and vitamin D supplement that is made from all-natural premium chocolate," stated Gene Dunkin, CEO of Thompson Brands. "This was not an easy task, considering the delicate balance between the calcium mineral’s inherent chalkiness, the recommended daily dosage in each serving size and the creamy texture and rich flavor we were trying to achieve."
Each chocolate Adora disk provides up to 50% of the daily value of calcium plus vitamin D3 and magnesium for optimal absorption. Adora calcium and vitamin D supplement is available in milk chocolate and dark chocolate flavors and can be found nationally at CVS/pharmacy stores, Whole Foods and other retailers for a suggested retail price of $9.99.